An experimental gene therapy for spinal cord pain shows promise in mice, researchers say. About half of spinal cord injury patients have neuropathy, which is chronic or debilitating pain, tingling, numbness or muscle weakness caused by damaged or malfunctioning nerves. Treatment of neuropathy can be challenging. For example, medications often require complex, continuous delivery and… read on > read on >

















-300x200.jpeg)

